Author
Meadows, KafiIyer, Seema
Stevens, Mark
Wang, Duanning
Shechter, Sharon
Perruzzi, Carole
Camenisch, Todd
Benjamin, Laura
Affiliation
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USADepartment of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona, USA
Issue Date
2009
Metadata
Show full item recordPublisher
BioMed CentralCitation
Journal of Angiogenesis Research 2009, 1:2 doi:10.1186/2040-2384-1-2Journal
Journal of Angiogenesis ResearchRights
© 2009 Meadows et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0).Collection Information
This item is part of the UA Faculty Publications collection. For more information this item or other items in the UA Campus Repository, contact the University of Arizona Libraries at repository@u.library.arizona.edu.Abstract
Endothelial to mesenchyme transition (EndMT) can be observed during the formation of endocardial cushions from the endocardium, the endothelial lining of the atrioventricular canal (AVC), of the developing heart at embryonic day 9.5 (E9.5). Many regulators of the process have been identifiedhowever, the mechanisms driving the initial commitment decision of endothelial cells to EndMT have been difficult to separate from processes required for mesenchymal proliferation and migration. We have several lines of evidence that suggest a central role for Akt signaling in committing endothelial cells to enter EndMT. Akt1 mRNA was restricted to the endocardium of endocardial cushions while they were forming. The PI3K/Akt signaling pathway is necessary for mesenchyme outgrowth, as sprouting was inhibited in AVC explant cultures treated with the PI3K inhibitor LY294002. Furthermore, endothelial marker, VE-cadherin, was downregulated and mesenchyme markers, N-cadherin and Snail, were induced in response to expression of a constitutively active form of Akt1 (myrAkt1) in endothelial cells. Finally, we isolated the function of Akt1 signaling in the commitment to the transition using a transgenic model where myrAkt1 was pulsed only in endocardial cells and turned off after EndMT initiation. In this way, we determined that increased Akt signaling in the endocardium drives EndMT and discounted its other functions in cushion mesenchymal cells.
EISSN
2040-2384Version
Final published versionAdditional Links
http://www.jangiogenesis.com/content/1/1/2ae974a485f413a2113503eed53cd6c53
10.1186/2040-2384-1-2
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © 2009 Meadows et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0).

